Last reviewed · How we verify
Chlorhexidine bath and nasal mupirocin
At a glance
| Generic name | Chlorhexidine bath and nasal mupirocin |
|---|---|
| Sponsor | Harvard Pilgrim Health Care |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients (PHASE4)
- Decolonization to Reduce After-Surgery Events of Surgical Site Infection (PHASE4)
- Mupirocin-Iodophor ICU Decolonization Swap Out Trial (PHASE4)
- A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA (NA)
- Study of the Impact of a Targeted Decolonization of S. Aureus Persistent Carriers (PHASE4)
- Checklist to Prevent MRSA Surgical Site Infections (NA)
- S. Aureus Screening and Decolonization (PHASE4)
- Active Bathing to Eliminate Infection (ABATE Infection) Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: